 ACTON, Mass.--BUSINESS WIRE--Insulet Corporation NASDAQ: PODD Insulet or the Company, the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced financial results for the three months ended June 30, 2021. Second Quarter Financial Highlights: Second quarter 2021 revenue of 263.2 million, up 16.3, or 12.5 in constant currency1, compared to 226.3 million in the prior year, within the guidance range of 10 to 14 on a constant currency basis 